NOTCH3 and lung carcinoma: Using a murine model of urethane-induced lung cancer and two cell models of NSCLC (A549 and H1299), Su et al. [50] demonstrated the modulatory role of EVO by using a DNMT inhibitor to investigate the role of NOTCH3 signaling in the anti-lung cancer effects of EVO.